University of Turin
Torino, Piemonte, Italy
Professor of Neurology and Neuro-Oncology, University of Turin, Dept. Neuroscience ‘Rita Levi Montalcini’; Head, Dept. Neuro-Oncology, City of Health and Science Hospital of Turin, Italy.President of European Association of Neuro-Oncology (EANO) (2012 to 2014); Chairperson of the Scientific Panel of Neuro-Oncology of the European Academy of Neurology (EAN) (2014-to date); Chairperson of the Research Group Neuro-Oncology of the World Federation of Neurology (WFN) (2014-to date); Member of the Steering Committee of the Brain Tumor Group of the European Organization for Research and Treatment of Cancer (EORTC); Member of the International Group Response Assessment in Neuro-Oncology (RANO) and Coordinator of the Section on Leptomeningeal Metastases. Specific research experience in: designing, coordinating and conducting clinico-translational trials in glioblastomas, lower grade gliomas, lymphomas, ependymomas, medulloblastomas, brain metastasis and neoplastic meningitis with new drugs; monitoring treatment effects with advanced neuroimaging techniques; evaluating prognostic and predictive value of molecular factors. About 157 original papers in highly impacted scientific journals, 8 books and 36 chapters of books. Executive Editor of Neuro-Oncology, Oxford University Press, (IF: 10.091); Section Editor (Neoplasms) of Current Opinion in Neurology (IF: 4.010); Section Editor (Neuro-Oncology) of Current Treatment Options in Neurology (IF: 2.633); Consulting Editor of Journal of Neurosurgical Sciences (IF: 1.767). Referee of international journals such as Lancet, Lancet Oncology, J Clinical Oncology, JAMA Oncology, Neurology, Lancet Neurology, Neurosurgery, etc. Award for Excellence in Clinical Research (Society for Neuro-Oncology, US, 2009)
